Sprouty-related proteins with EVH1 domain (SPRED2) prevents high-glucose induced endothelial–mesenchymal transition and endothelial injury by suppressing MAPK activation
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Diabetic retinopathy (DR) is a common complication of diabetes, and the leading cause of blindness in adults. Sprouty-related proteins with EVH1 domain (SPRED2) play an important role in diabetes and are closely related to the lens and eye morphogenesis. This study attempted to investigate the role and related mechanism of SPRED2 in DR. DR rat model was established by administration streptozocin. Human retinal endothelial cells (HRECs) were treated with high glucose (HG) to mimic DR. The results showed that SPRED2 expression was decreased in the retinal tissues of DR rats and HG-treated HRECs. MTT assay and flow cytometry data showed that SPRED2 overexpression reduced cell viability of HG-treated HRECs. SPRED2 overexpression enhanced Caspase-3 activity and promoted apoptosis of HG-treated HRECs. Furthermore, the expressions of endothelial cell markers CD31 and E-cad were down-regulated, whereas the expressions of mesenchymal cell markers FSP1, SM22, and α-SMA were up-regulated in the HG-treated HRECs. SPRED2 overexpression reversed HG-induced endothelial-mesenchymal transition in HRECs. The expressions of tight junction components claudin 3, occludin, and ZO-1 were increased in HG-treated HRECs following SPRED2 up-regulation. In addition, SPRED2 overexpression downregulated the expression of p-ERK1/2, p-p38, and p-JNK in the HG-treated HRECs. In conclusion, this study demonstrated that SPRED2 overexpression repressed endothelial-mesenchymal transition and endothelial injury in HG-treated HRECs by suppressing MAPK signaling pathway. These findings suggested that SPRED2 may be a novel potential therapeutic target implicated in DR progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“while ERK and JNK phosphorylation is inversely correlated with the expression of tight junction components in human retinal endothelial cells in vitro [ 92 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Tian, M., Yang, J. H., Xia, Y., Cao, Y., Liu, Y., Lei, Y., & Lv, H. (2022) · Bioengineered · doi:10.1080/21655979.2022.2075306 · Cited by 15
RetractedWang, Y., & Li, C. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/8366569 · Cited by 10
RetractedGlobal estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
Lee, R., Wong, T. Y., & Sabanayagam, C. (2015) · Eye and Vision · doi:10.1186/s40662-015-0026-2 · Cited by 1,569
Ting, D. S. W., Cheung, G. C. M., & Wong, T. Y. (2016) · Clinical & Experimental Ophthalmology · doi:10.1111/ceo.12696 · Cited by 1,066
Cunha-Vaz, J., Bernardes, R., & Lobo, C. (2011) · European Journal of Ophthalmology · doi:10.5301/ejo.2010.6049 · Cited by 539
VEGF-initiated blood-retinal barrier breakdown in early diabetes.
Qaum, T., Xu, Q., Joussen, A. M., Clemens, M. W., Qin, W., Miyamoto, K., Hasséssian, H., Wiegand, S. J., Rudge, J. S., Yancopoulos, G. D., et al. (2001) · PubMed · Cited by 508
The pathology associated with diabetic retinopathy
Lechner, J., O'Leary, O. E., & Stitt, A. W. (2017) · Vision Research · doi:10.1016/j.visres.2017.04.003 · Cited by 474
Peng, W., Li, J., Chen, R., Gu, Q., Yang, P., Qian, W., Ji, D., Wang, Q., Zhang, Z., Tang, J., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1408-4 · Cited by 373
lncRNA H19 prevents endothelial–mesenchymal transition in diabetic retinopathy
Thomas, A. A., Biswas, S., Feng, B., Chen, S., Gonder, J., & Chakrabarti, S. (2019) · Diabetologia · doi:10.1007/s00125-018-4797-6 · Cited by 213
Research works printed but not linked: 1
- 10.1096/fj.201802614rrr · DOI
Cited by
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
“At the same time, a balanced p38/TXNIP/NFκB pathway inhibition is required for proper tight junctions in the inner blood–retinal barrier [87] and for the prevention of macular edema [88–91], while ERK and JNK phosphorylation is inversely correlated with the expression of tight junction components in human retinal endo…”
BackgroundFerroptosis: a novel mechanism of cell death in ophthalmic conditions
Yang, Y., Lin, Y., Han, Z., Wang, B., Zheng, W., & Wei, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1440309 · Cited by 46
Mimouni, M., Lajoix, A., & Desmetz, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010382 · Cited by 17
Endothelial to mesenchymal cell transition in diabetic retinopathy: targets and therapeutics
Nijim, W., Moustafa, M., Humble, J., & Al‐Shabrawey, M. (2023) · Frontiers in Ophthalmology · doi:10.3389/fopht.2023.1230581 · Cited by 15
Redefining cell death: ferroptosis as a game-changer in ophthalmology
Wei, Y., Lin, Y., Li, Y., Liu, J., Yang, Y., Chen, H., Han, Z., Wang, K., Tao, Q., Ju, Y., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1709354 · Cited by 10
Metadata
- Authors
- Liu, T., Zhao, J., & Lin, C.
- Affiliations
- First People’s Hospital of Jingmen (CN)
- Wenzhou Hospital of Traditional Chinese Medicine (CN)
- Corresponding author
- Lin, Chengmin
- Venue
- Bioengineered
- Publisher
- Informa UK Limited
- Published
- 2022-05-02
- Volume
- 13
- Issue
- 5
- Pages
- 13882-13892
- ISSN
- 2165-5979 (ISSN-L)
- 2165-5987
- PMC
- PMC9275976
- OpenAlex
- W4283020754
- Cited by
- 12
- References
- 43
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 4
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0/ (unspecified)
- doi.org/10.1080/policies-text-data-mining (tdm)
- Locations
- Bioengineered (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Figshare (cc-by)
- Funders
- reported
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- SPRED2, diabetic retinopathy, endothelial-to-mesenchymal transition, high glucose, retinal endothelial cells, MAPK signaling, ERK1/2, p38 MAPK, JNK, endothelial injury, apoptosis, tight junctions, streptozotocin-induced diabetes, therapeutic target
- MeSH terms
- Animals, Diabetic Retinopathy, Glucose, Retina, Signal Transduction, Endothelial Cells, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sprouty-related proteins with EVH1 domain (SPRED2) prevents high-glucose induced endothelial–mesenchymal transition and endothelial injury by suppressing MAPK activation. https://app.cochat.ai/papers/10.1080/21655979.2022.2086351
- The paper
- Liu, T., Zhao, J., & Lin, C. (2022). Sprouty-related proteins with EVH1 domain (SPRED2) prevents high-glucose induced endothelial–mesenchymal transition and endothelial injury by suppressing MAPK activation. Bioengineered. https://doi.org/10.1080/21655979.2022.2086351
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.